GlassScriptPhysician profile
Sherrone D Simon
NPI 1992840094
$1,340.35
in general payments reported to CMS, 2019-2025
13 companies · $520 in 2025
The $520 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $105 · 2021: $190 · 2024: $158 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $298.68 | 2025 | Rezdiffra |
| Glaxosmithkline, LLC. | $256.18 | 2019-2021 | |
| Dexcom, INC. | $171.07 | 2021-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $112.29 | 2019 | |
| Phathom Pharmaceuticals, INC. | $111.86 | 2024 | Voquezna |
| Amarin Pharma, INC. | $109.06 | 2019 | |
| Organon LLC | $88.33 | 2025 | Jada System, Nexplanon |
| Exact Sciences Corporation | $48.41 | 2024-2025 | Cologuard Collection Kit |
| Mallinckrodt Enterprises LLC | $38.16 | 2019 | |
| Merck Sharp & Dohme LLC | $37.54 | 2021 | |
| Seqirus USA INC | $26.03 | 2025 | Fluad, Flucelvax |
| Hologic Sales and Service, LLC | $21.96 | 2024 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Cranial Technologies, INC | $20.78 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherrone Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.